NISA INVESTMENT ADVISORS, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$24
-99.9%
3,800
-1.9%
0.00%
Q3 2022$31,000
+29.2%
3,874
+1.9%
0.00%
Q2 2022$24,000
+33.3%
3,8000.0%0.00%
Q1 2022$18,000
+260.0%
3,800
+838.3%
0.00%
Q3 2021$5,000
-44.4%
4050.0%0.00%
Q2 2021$9,000
-86.6%
405
-83.2%
0.00%
Q1 2021$67,000
+6.3%
2,4050.0%0.00%
Q4 2020$63,000
+600.0%
2,405
+843.1%
0.00%
Q3 2020$9,000
-30.8%
2550.0%0.00%
Q2 2020$13,000
+116.7%
255
+27.5%
0.00%
Q1 2020$6,000
-50.0%
2000.0%0.00%
Q4 2019$12,000
+71.4%
2000.0%0.00%
Q3 2019$7,000
+16.7%
200
+53.8%
0.00%
Q2 2019$6,000
+20.0%
1300.0%0.00%
Q1 2019$5,000
-16.7%
1300.0%0.00%
Q4 2018$6,0000.0%1300.0%0.00%
Q3 2018$6,000
-40.0%
130
-50.0%
0.00%
Q2 2018$10,000
-9.1%
260
+73.3%
0.00%
Q1 2018$11,000
-31.2%
150
-40.0%
0.00%
Q4 2017$16,0002500.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 2,629,835$116,685,00025.08%
Aviva Holdings Ltd. 1,200,100$53,248,00014.21%
Boxer Capital, LLC 1,375,000$61,009,0006.77%
BB BIOTECH AG 3,282,964$145,665,0003.86%
Rhenman & Partners Asset Management AB 353,961$15,705,0001.57%
PFM Health Sciences, LP 1,970,134$87,415,0001.28%
Bellevue Group AG 391,852$17,386,0001.10%
Pentwater Capital Management LP 2,351,500$104,336,0000.88%
Partner Investment Management, L.P. 25,440$1,129,0000.86%
SABBY MANAGEMENT, LLC 100,369$4,453,0000.57%
View complete list of ESPERION THERAPEUTICS INC NE shareholders